XML 21 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Condensed Balance Sheets - USD ($)
$ in Millions
Sep. 27, 2025
Sep. 28, 2024
Assets    
Cash and cash equivalents $ 1,229 $ 1,717
Accounts receivable, net 2,524 2,406
Inventories 5,681 5,195
Other current assets 482 433
Total Current Assets 9,916 9,751
Net Property, Plant and Equipment 9,204 9,442
Goodwill, net 9,469 9,819
Intangible Assets, net 5,624 5,875
Other Assets 2,445 2,213
Total Assets 36,658 37,100
Liabilities and Shareholders' Equity    
Current debt 909 74
Accounts payable 2,601 2,402
Other current liabilities 2,879 2,311
Total Current Liabilities 6,389 4,787
Total long-term debt 7,921 9,713
Deferred Income Taxes 2,195 2,285
Other Liabilities 1,926 1,801
Shareholders' Equity:    
Capital in excess of par value 4,686 4,597
Retained earnings 18,647 18,873
Accumulated other comprehensive gain (loss) (191) (184)
Treasury stock, at cost – 88 million shares at October 1, 2022 and 83 million shares at October 2, 2021 (5,102) (4,941)
Total Tyson Shareholders’ Equity 18,085 18,390
Noncontrolling Interests 142 124
Total Shareholders’ Equity 18,227 18,514
Total Liabilities and Shareholders’ Equity 36,658 37,100
Class A [Member]    
Shareholders' Equity:    
Common stock ($0.10 par value): 38 38
Class B [Member]    
Shareholders' Equity:    
Common stock ($0.10 par value): $ 7 $ 7